AI-generated summary
The authors studied transcranial photobiomodulation using a 1064 nm laser in rats to assess pain relief. They report that the treatment reduced nociceptive behavior, increased cortical local field potential signals, and reduced pain-induced brain hyperactivity while sustaining brain connectivity. The abstract describes these as animal findings and presents tPBM as a potential non-invasive approach for pain management.
- Who or what was studied
- Rats
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The study was conducted in rats, so the findings may not translate directly to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on physoc.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Laser, Near-infrared, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.